Bacillus anthracis: balancing innocent research with dual-use potential
- PMID: 18375178
- PMCID: PMC7106442
- DOI: 10.1016/j.ijmm.2007.09.007
Bacillus anthracis: balancing innocent research with dual-use potential
Abstract
Anthrax Euronet, a Coordination Action of the EU 6th Framework Programme, was designed to strengthen networking activities between anthrax research groups in Europe and to harmonise protocols for testing anthrax vaccines and therapeutics. Inevitably, the project also addressed aspects of the current political issues of biosecurity and dual-use research, i.e. research into agents of important diseases of man, livestock or agriculture that could be used as agents of bioterrorism. This review provides a comprehensive overview of the biology of Bacillus anthracis, of the pathogenesis, epidemiology and diagnosis of anthrax, as well as vaccine and therapeutic intervention strategies. The proposed requirement for a code of conduct for working with dual-use agents such as the anthrax bacillus is also discussed.
Figures



Similar articles
-
The development of new vaccines against Bacillus anthracis.J Appl Microbiol. 2001 Oct;91(4):609-13. doi: 10.1046/j.1365-2672.2001.01498.x. J Appl Microbiol. 2001. PMID: 11576296 Review. No abstract available.
-
Anthrax, toxins and vaccines: a 125-year journey targeting Bacillus anthracis.Expert Rev Anti Infect Ther. 2009 Mar;7(2):219-36. doi: 10.1586/14787210.7.2.219. Expert Rev Anti Infect Ther. 2009. PMID: 19254170 Review.
-
Bacillus anthracis, a story of nature subverted by man.Lett Appl Microbiol. 2005;41(3):227-9. doi: 10.1111/j.1472-765X.2005.01786.x. Lett Appl Microbiol. 2005. PMID: 16108911 Review.
-
Learning from the 2001 anthrax attacks: immunological characteristics.J Infect Dis. 2007 Jan 15;195(2):163-4. doi: 10.1086/510317. Epub 2006 Dec 6. J Infect Dis. 2007. PMID: 17191158 No abstract available.
-
Molecular study of genes involved in virulence regulatory pathways in Bacillus anthracis vaccine strain "Carbosap".New Microbiol. 2006 Oct;29(4):307-10. New Microbiol. 2006. PMID: 17201098
Cited by
-
The role of anthrolysin O in gut epithelial barrier disruption during Bacillus anthracis infection.Biochem Biophys Res Commun. 2010 Apr 2;394(2):254-9. doi: 10.1016/j.bbrc.2010.02.091. Epub 2010 Feb 25. Biochem Biophys Res Commun. 2010. PMID: 20188700 Free PMC article.
-
ATP depletion in anthrax edema toxin pathogenesis.PLoS Pathog. 2025 Apr 1;21(4):e1013017. doi: 10.1371/journal.ppat.1013017. eCollection 2025 Apr. PLoS Pathog. 2025. PMID: 40168442 Free PMC article.
-
From structure to solutions: the role of basic research in developing anthrax countermeasures: Microbiology Graduate Program Seminar: Anthrax toxin.Yale J Biol Med. 2012 Jun;85(2):285-92. Epub 2012 Jun 25. Yale J Biol Med. 2012. PMID: 22737057 Free PMC article.
-
Livestock owners' anthrax prevention practices and its associated factors in Sekota Zuria district, Northeast Ethiopia.BMC Vet Res. 2020 Feb 3;16(1):39. doi: 10.1186/s12917-020-2267-0. BMC Vet Res. 2020. PMID: 32013973 Free PMC article.
-
Targeted silencing of anthrax toxin receptors protects against anthrax toxins.J Biol Chem. 2014 May 30;289(22):15730-8. doi: 10.1074/jbc.M113.538587. Epub 2014 Apr 17. J Biol Chem. 2014. PMID: 24742682 Free PMC article.
References
-
- Abrami L., Reig N., van der Goot F.G. Anthrax toxin: the long and winding road that leads to the kill. Trends Microbiol. 2005;13:72–78. - PubMed
-
- Baillie L.W.J. Past, imminent and future human medical countermeasures for anthrax. J. Appl. Microbiol. 2006;101:594–606. - PubMed
-
- Baldari C.T., Tonello F., Paccani S.R., Montecucco C. Anthrax toxins: a paradigm of bacterial immune suppression. Trends Immunol. 2006;27:434–440. - PubMed
-
- Beyer W. Vaccination strategies for anthrax prevention. Berl. Münch. Tierarztl. Wochenschr. 2004;117:508–524. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical